Follow
Stephen Gottschalk
Stephen Gottschalk
Verified email at stjude.org - Homepage
Title
Cited by
Cited by
Year
Human epidermal growth factor receptor 2 (HER2)–specific chimeric antigen receptor–modified T cells for the immunotherapy of HER2-positive sarcoma
N Ahmed, VS Brawley, M Hegde, C Robertson, A Ghazi, C Gerken, E Liu, ...
Journal of clinical oncology 33 (15), 1688, 2015
10002015
HER2-specific chimeric antigen receptor–modified virus-specific T cells for progressive glioblastoma: a phase 1 dose-escalation trial
N Ahmed, V Brawley, M Hegde, K Bielamowicz, M Kalra, D Landi, ...
JAMA oncology 3 (8), 1094-1101, 2017
6852017
Design and development of therapies using chimeric antigen receptor‐expressing T cells
G Dotti, S Gottschalk, B Savoldo, MK Brenner
Immunological reviews 257 (1), 107-126, 2014
6442014
Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape
M Hegde, M Mukherjee, Z Grada, A Pignata, D Landi, SA Navai, ...
The Journal of clinical investigation 126 (8), 3036-3052, 2016
6222016
Post-transplant lymphoproliferative disorders
S Gottschalk, CM Rooney, HE Heslop
Annu. Rev. Med. 56, 29-44, 2005
5462005
Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins
CM Bollard, S Gottschalk, V Torrano, O Diouf, S Ku, Y Hazrat, G Carrum, ...
Journal of Clinical Oncology 32 (8), 798, 2014
5192014
TanCAR: a novel bispecific chimeric antigen receptor for cancer immunotherapy
Z Grada, M Hegde, T Byrd, DR Shaffer, A Ghazi, VS Brawley, A Corder, ...
Molecular Therapy-Nucleic Acids 2, 2013
5062013
A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells.
S Gottschalk, JT Sparrow, J Hauer, MP Mims, FE Leland, SL Woo, ...
Gene therapy 3 (5), 448-457, 1996
4161996
Off-the-shelf virus-specific T cells to treat BK virus, human herpesvirus 6, cytomegalovirus, Epstein-Barr virus, and adenovirus infections after allogeneic hematopoietic stem …
I Tzannou, A Papadopoulou, S Naik, K Leung, CA Martinez, CA Ramos, ...
Journal of Clinical Oncology 35 (31), 3547, 2017
4142017
HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors
N Ahmed, VS Salsman, Y Kew, D Shaffer, S Powell, YJ Zhang, ...
Clinical cancer research 16 (2), 474-485, 2010
3992010
Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma
M Hegde, A Corder, KKH Chow, M Mukherjee, A Ashoori, Y Kew, ...
Molecular Therapy 21 (11), 2087-2101, 2013
3892013
Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States
JI Cohen, ES Jaffe, JK Dale, S Pittaluga, HE Heslop, CM Rooney, ...
Blood, The Journal of the American Society of Hematology 117 (22), 5835-5849, 2011
3542011
Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer
CM Bollard, S Gottschalk, AM Leen, H Weiss, KC Straathof, G Carrum, ...
Blood, The Journal of the American Society of Hematology 110 (8), 2838-2845, 2007
3402007
An Epstein-Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs
S Gottschalk, CYC Ng, M Perez, CA Smith, C Sample, MK Brenner, ...
Blood, The Journal of the American Society of Hematology 97 (4), 835-843, 2001
3212001
Antitumor effects of chimeric receptor engineered human T cells directed to tumor stroma
S Kakarla, KKH Chow, M Mata, DR Shaffer, XT Song, MF Wu, H Liu, ...
Molecular Therapy 21 (8), 1611-1620, 2013
3202013
Treatment of solid organ transplant recipients with autologous Epstein Barr virus–specific cytotoxic T lymphocytes (CTLs)
B Savoldo, JA Goss, MM Hammer, L Zhang, T Lopez, AP Gee, YF Lin, ...
Blood 108 (9), 2942-2949, 2006
2992006
Adoptive T-cell transfer and chemotherapy in the first-line treatment of metastatic and/or locally recurrent nasopharyngeal carcinoma
WK Chia, M Teo, WW Wang, B Lee, SF Ang, WM Tai, CL Chee, J Ng, ...
Molecular Therapy 22 (1), 132-139, 2014
2732014
T cells redirected to EphA2 for the immunotherapy of glioblastoma
KKH Chow, S Naik, S Kakarla, VS Brawley, DR Shaffer, Z Yi, N Rainusso, ...
Molecular Therapy 21 (3), 629-637, 2013
2682013
Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma
CU Louis, K Straathof, CM Bollard, S Ennamuri, C Gerken, TT Lopez, ...
Journal of immunotherapy 33 (9), 983-990, 2010
2662010
Transgenic expression of IL15 improves antiglioma activity of IL13Rα2-CAR T cells but results in antigen loss variants
G Krenciute, BL Prinzing, Z Yi, MF Wu, H Liu, G Dotti, IV Balyasnikova, ...
Cancer immunology research 5 (7), 571-581, 2017
2632017
The system can't perform the operation now. Try again later.
Articles 1–20